SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-094661
Filing Date
2020-04-01
Accepted
2020-04-01 16:23:10
Documents
14
Period of Report
2020-04-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d905486d8k.htm   iXBRL 8-K 30398
2 EX-99.1 d905486dex991.htm EX-99.1 12962
6 GRAPHIC g905486g0401211157265.jpg GRAPHIC 2714
  Complete submission text file 0001193125-20-094661.txt   179501

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zyme-20200401.xsd EX-101.SCH 3094
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20200401_lab.xml EX-101.LAB 18856
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20200401_pre.xml EX-101.PRE 11864
15 EXTRACTED XBRL INSTANCE DOCUMENT d905486d8k_htm.xml XML 3455
Mailing Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9
Business Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9 (604) 678-1388
Zymeworks Inc. (Filer) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38068 | Film No.: 20765699
SIC: 2834 Pharmaceutical Preparations